 |
recombinant human monoclonal IgG1 antibody against programmed death ligand-1 (anti-PD-L1) |
|---|---|
| Trade Name | |
| Orphan Indication | Merkel cell cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-21 00:00:00 |
| Sponsor | EMD Serono, Inc.;45 Middlesex Turnpike;Billerica, Massachusetts, 01821 |
Related Access Program